These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38847110)

  • 21. Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors.
    Tenório JDR; da Silva LP; Xavier MGA; Santana T; do Nascimento GJF; Sobral APV
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2341-2347. PubMed ID: 30003391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma.
    Mosconi C; Arantes DAC; Gonçalves AS; Alencar RCG; Oliveira JC; Silva TA; Mendonça EF; Batista AC
    Arch Oral Biol; 2017 Nov; 83():55-62. PubMed ID: 28711734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
    Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
    Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SALTT study: A retrospective analysis of 111 SAlivary gland tumors of Lung and Tracheobronchial Tree.
    Batra N; Mishra P; Pai T; Jiwnani S; Karimundackal G; Tiwari V; Purandare N; Janu A; Noronha V; Joshi A; Prabhash K; Tibdewal A; Agarwal JP; Pramesh CS; Kaushal RK
    Ann Diagn Pathol; 2024 Jun; 70():152283. PubMed ID: 38447254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes.
    Sridharan V; Gjini E; Liao X; Chau NG; Haddad RI; Severgnini M; Hammerman P; El-Naggar A; Freeman GJ; Hodi FS; Rodig SJ; Dranoff G; Schoenfeld JD
    Cancer Immunol Res; 2016 Aug; 4(8):679-87. PubMed ID: 27312343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 expression in malignant salivary gland tumors.
    Harada K; Ferdous T; Ueyama Y
    BMC Cancer; 2018 Feb; 18(1):156. PubMed ID: 29409471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.
    Matsubara T; Takada K; Azuma K; Takamori S; Toyokawa G; Haro A; Osoegawa A; Tagawa T; Kawahara A; Akiba J; Okamoto I; Nakanishi Y; Oda Y; Hoshino T; Maehara Y
    Ann Surg Oncol; 2019 Jun; 26(6):1925-1933. PubMed ID: 30815803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
    Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
    J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma.
    Furuse M; Kuwabara H; Ikeda N; Hattori Y; Ichikawa T; Kagawa N; Kikuta K; Tamai S; Nakada M; Wakabayashi T; Wanibuchi M; Kuroiwa T; Hirose Y; Miyatake SI
    BMC Cancer; 2020 Apr; 20(1):277. PubMed ID: 32248797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
    Del C Monroig-Bosque P; Driver B; Morales-Rosado JA; Deavers M; Tacha D; Bernicker E; Cagle PT; Miller RA
    Arch Pathol Lab Med; 2018 Nov; 142(11):1388-1393. PubMed ID: 29431467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implication of CD166 expression in salivary gland tumor.
    Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
    Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Expression of Programmed Death Ligand 1 and Programmed Death Ligand 2 in Ophthalmic Sebaceous Carcinoma: The Case for a Clinical Trial of Checkpoint Inhibitors.
    Wolkow N; Jakobiec FA; Afrogheh AH; Pai SI; Faquin WC
    Am J Ophthalmol; 2020 Dec; 220():128-139. PubMed ID: 32730911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.
    Wolkow N; Jakobiec FA; Afrogheh AH; Eagle RC; Pai SI; Faquin WC
    Am J Ophthalmol; 2019 Apr; 200():226-241. PubMed ID: 30633894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of epidermal growth factor receptor in various pathological types of salivary gland cancers.
    Fujiwara H; Kodama Y; Shimoda H; Teshima M; Shinomiya H; Nibu KI
    Auris Nasus Larynx; 2024 Aug; 51(4):755-760. PubMed ID: 38852332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-L1 and PD-L2 Expression Levels Are Low in Primary and Secondary Adenoid Cystic Carcinomas of the Orbit: Therapeutic Implications.
    Wolkow N; Jakobiec FA; Afrogheh AH; Kidd M; Eagle RC; Pai SI; Faquin WC
    Ophthalmic Plast Reconstr Surg; 2020; 36(5):444-450. PubMed ID: 31990894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
    Lee JH; Lee JH; Kim A; Kim I; Chae YS
    Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.
    Seo AN; Kang BW; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Bae HI; Jeon SW; Kang H; Kim JG
    Br J Cancer; 2017 Dec; 117(12):1753-1760. PubMed ID: 29073638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry.
    Shinchi Y; Komohara Y; Yonemitsu K; Sato K; Ohnishi K; Saito Y; Fujiwara Y; Mori T; Shiraishi K; Ikeda K; Suzuki M
    Cancer Sci; 2019 Sep; 110(9):2711-2721. PubMed ID: 31294893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.